Who has invested in UniXell Biotechnology?

Shanghai State-owned Assets are named among the investors backing UniXell Biotechnology.

UniXell Biotechnology Funding: $140M Raised, Series A (2026)

UniXell Biotechnology funding overview

UniXell Biotechnology has raised $140M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series A announced in February 2026. The round record for UniXell Biotechnology runs through 2026; nothing later has been disclosed. Investors on record include Shanghai State-owned Assets.

UniXell Biotechnology at a glance

Total raised: $140M
Latest round: Series A
Latest round date: February 2026
Notable investors: Shanghai State-owned Assets

Frequently asked about UniXell Biotechnology funding

How much has UniXell Biotechnology raised?: UniXell Biotechnology has raised $140M in total disclosed funding across the rounds on record.
Who has invested in UniXell Biotechnology?: Shanghai State-owned Assets are named among the investors backing UniXell Biotechnology.
What was the latest UniXell Biotechnology funding round?: The most recent disclosed round is a Series A, announced in February 2026.
Where is UniXell Biotechnology based?: No headquarters location is disclosed for UniXell Biotechnology.
When did UniXell Biotechnology last raise?: The last disclosed UniXell Biotechnology round closed in February 2026 at Series A.

Round data for UniXell Biotechnology is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies and backer lists below.

UniXell Biotechnology Funding: $140M Raised, Series A (2026)

UniXell Biotechnology funding overview

UniXell Biotechnology at a glance

Frequently asked about UniXell Biotechnology funding

Companies related to UniXell Biotechnology (30)

Browse related funding lists (3)